A detailed history of Citigroup Inc transactions in Organon & Co. stock. As of the latest transaction made, Citigroup Inc holds 180,268 shares of OGN stock, worth $2.75 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
180,268
Previous 162,052 11.24%
Holding current value
$2.75 Million
Previous $3.35 Million 2.8%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$18.65 - $23.03 $339,728 - $419,514
18,216 Added 11.24%
180,268 $3.45 Million
Q2 2024

Aug 12, 2024

SELL
$17.45 - $21.96 $1.26 Million - $1.59 Million
-72,183 Reduced 30.82%
162,052 $3.35 Million
Q1 2024

May 10, 2024

SELL
$13.78 - $18.8 $16,232 - $22,146
-1,178 Reduced 0.5%
234,235 $4.4 Million
Q4 2023

Feb 09, 2024

SELL
$10.95 - $17.32 $2.6 Million - $4.11 Million
-237,218 Reduced 50.19%
235,413 $3.39 Million
Q3 2023

Nov 09, 2023

BUY
$16.59 - $23.77 $2.68 Million - $3.83 Million
161,249 Added 51.78%
472,631 $8.2 Million
Q2 2023

Aug 10, 2023

BUY
$19.27 - $24.63 $2.46 Million - $3.15 Million
127,703 Added 69.53%
311,382 $6.48 Million
Q1 2023

May 11, 2023

BUY
$21.42 - $32.08 $745,801 - $1.12 Million
34,818 Added 23.39%
183,679 $4.32 Million
Q4 2022

Feb 09, 2023

SELL
$23.31 - $28.61 $183,006 - $224,617
-7,851 Reduced 5.01%
148,861 $4.16 Million
Q3 2022

Nov 10, 2022

BUY
$23.4 - $34.25 $1.59 Million - $2.33 Million
68,147 Added 76.95%
156,712 $3.67 Million
Q2 2022

Aug 10, 2022

SELL
$31.66 - $38.9 $815,434 - $1 Million
-25,756 Reduced 22.53%
88,565 $2.99 Million
Q1 2022

May 12, 2022

SELL
$30.45 - $39.36 $789,933 - $1.02 Million
-25,942 Reduced 18.5%
114,321 $3.99 Million
Q4 2021

Feb 10, 2022

SELL
$28.67 - $37.13 $1.55 Million - $2 Million
-53,996 Reduced 27.8%
140,263 $4.27 Million
Q3 2021

Nov 10, 2021

BUY
$28.63 - $35.64 $5.56 Million - $6.92 Million
194,259 New
194,259 $6.37 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.89B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.